Schizophrenic Patients in Integrated Care
Schizophrenic Patients in Integrated Care
The purpose of the study is to investigate the well-being of schizophrenic patients treated
 with quetiapine XR combined with participation in the integrated care program compared to a
 treatment with quetiapine XR alone over a period of 18 month
Inclusion Criteria:

 -  Patients with baseline SWN-K <=70

 -  Provision of signed informed consent

 -  Out-patients with schizophrenia, schizophreniform disorder or schizoaffective
 disorder, severe postpartum depressive disorders with psychotic symptoms and a minimum
 HAM-D cut off score of 20 points

 Exclusion Criteria:

 -  Evidence of a clinical relevant disease, eg renal or hepatic impairment, significant
 coronary heart disease, hepatitis B or C, AIDS

 -  Patients with known cardiovascular disease or other condition predisposing to
 hypotension or family history of QT prolongation

 -  Patients who pose an imminent risk of suicide or danger to self or others